Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Net Change in Cash

Adverum Biotechnlgs Net Change in Cash Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Net Change in Cash from 2013 to 2020.
  • Adverum Biotechnlgs Net Change in Cash for the quarter ending June 06, 2020 was $-103m a 76.03% decrease of -78m year over year
  • Adverum Biotechnlgs Net Change in Cash for the last 12 months ending June 06, 2020 was $-70m a -22.79% increase of 16m year over year
  • Adverum Biotechnlgs Annual Net Change in Cash for 2019 was $-89m a 195.93% decrease of -174m from 2018
  • Adverum Biotechnlgs Annual Net Change in Cash for 2018 was $85m a 277.52% increase of 237m from 2017
  • Adverum Biotechnlgs Annual Net Change in Cash for 2017 was $-152m a 100.54% decrease of -152m from 2016
Other Cash Flow Metrics:
  • Adverum Biotechnlgs Cash Flow from Operations for the quarter ending December 12, 2018 was $-13m a -2.00% increase of 0m year over year
  • Adverum Biotechnlgs Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-26m a 70.14% decrease of -18m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Net Change in Cash Data

06/2020$-103m
03/2020$64m
12/2019$-7m
09/2019$-25m
06/2019$-46m
03/2019$-11m
12/2018$-5m
09/2018$4m
06/2018$4m
03/2018$82m

Annual ADVM Net Change in Cash Data

2019$-89m
2018$85m
2017$-152m
2016$1m
2015$62m
2014$159m
2013$0m
2012$-1m